Macron sees Daesh military defeat in Syria, Iraq within ‘weeks’

French President Emmanuel Macron said that Daesh in Syria and Iraq would be defeated militarily “in the coming weeks.”(AFP)
Updated 20 January 2018

Macron sees Daesh military defeat in Syria, Iraq within ‘weeks’

TOULON: French President Emmanuel Macron said Friday that the Daesh organization in Syria and Iraq would be defeated militarily “in the coming weeks,” as he laid out plans for bolstering France’s defense capabilities.
“Today, thanks to the efforts of all the nations involved, the Daesh military organization in the Levant is almost completely defeated,” Macron said in a speech aboard a helicopter carrier in the southern port of Toulon.
“I’m confident that in the coming weeks we will achieve a military victory on the ground,” he said.
“I want us now to firmly commit with our partners to stabilization, reconstruction and aide to populations” after years of conflict, he said.
With many of its leaders dead and its fighters on the run, IS has now lost almost all the land it once controlled in Syria and Iraq.
France, which recently pulled out two of the 12 Rafale fighter jets it had been operating in the region, currently has about 1,200 personnel in the international coalition fighting the militants.
Macron said that although combat operations would continue, the country would “adapt” its contribution this year to developments, without providing details.
The French government has increased the 2018 defense budget by 1.8 billion euros, bringing it to 34.2 billion euros ($42 billion).
Macron reiterated his pledge to lift French defense spending to two percent of the country’s GDP by 2025, in line with the target agreed to by NATO members in 2014.
The increased spending will include a “renewal” of France’s nuclear arsenal during his five-year term, Macron said, calling nuclear deterrence “the keystone of our defense strategy for the past 50 years.”


UK vaccine frontrunner could be available in first half of 2021

Updated 27 min 45 sec ago

UK vaccine frontrunner could be available in first half of 2021

  • Human trials of the vaccine will expand to hundreds more people in the “coming weeks.”

LONDON: A leading British scientist has said a Covid-19 vaccine could be rolled out across the country as early as the first half of next year.

Professor Robin Shattock leads the team working on Imperial College London’s vaccine, one of the UK’s two most promising research programs. He told Sky News: “We anticipate if everything goes really well, that we'll get an answer as to whether it works by early next year.

“Assuming that the funding is there to purchase that vaccine, we could have that vaccine rolled out across the UK in the first half of next year.”

Shattock also warned that there was “no certainty” that any of the vaccines currently being developed would work, but said the risk of that is “very, very low.”

Imperial College London is now conducting human trials of their vaccine, with 15 volunteers having received it so far. Shattock said this will be ramped up in the “coming weeks” to include another 200 to 300 patients.

“I think we're very lucky in the UK that we have two very strong candidates, the one from Imperial, the one from Oxford, and so we’re pretty well placed, but there's still not a certainty that either of those two will work,” he said.

Oxford University is also developing a vaccination for Covid-19, in partnership with British-Swedish pharmaceutical giant AstraZeneca.

While Shattock said he hopes Imperial College London’s vaccine will be available for the whole of the UK in the first half of next year, it is unclear how long it would take for it to be available outside of the country.

The UK, European Union and the US have all invested huge sums into vaccine development, and struck deals with pharmaceutical companies worth hundreds of millions of dollars each to ensure first-in-line access to successful vaccinations.

However, international organizations such as the UN, International Red Crescent and Red Cross, and Doctors Without Borders have raised concerns that the world’s poorest countries will be unable to access vaccinations and effective Covid-19 treatments due to rich countries outspending them.